Company Filing History:
Years Active: 2015
Title: Innovations by Selena Y Lin in Cancer Screening
Introduction
Selena Y Lin is an accomplished inventor based in West Chester, PA (US). She has made significant contributions to the field of cancer diagnostics, particularly through her innovative patent related to hepatocellular carcinoma (HCC) screening.
Latest Patents
Selena holds a patent for a P53 assay designed for a urine test aimed at screening for HCC. This rapid and sensitive assay detects p53 mutations in urine, utilizing a locked nucleic acid (LNA) clamp mediated one-step PCR-based method. The assay boasts a remarkable sensitivity of up to a single copy and is versatile enough to be applied to various biological samples. It is particularly beneficial for detecting multiple types of cancer, including hepatocellular carcinoma, colon cancer, breast cancer, lung cancer, prostate cancer, ovarian cancer, bladder cancer, lymphoma, and stomach cancer.
Career Highlights
Selena is affiliated with Drexel University, where she continues to advance her research and innovations in cancer diagnostics. Her work has the potential to significantly improve early detection and treatment outcomes for cancer patients.
Collaborations
Selena collaborates with Ying-Hsiu Su, who is also a notable figure in the field. Their partnership enhances the research and development of innovative cancer screening methods.
Conclusion
Selena Y Lin's contributions to cancer diagnostics through her patented P53 assay exemplify the impact of innovation in medical technology. Her work not only advances scientific knowledge but also holds promise for improving patient care in oncology.